Patents by Inventor Brian Andrew

Brian Andrew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antagonists of Prostaglandin D2 Receptors
    Publication number: 20110190227
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists Of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: July 2, 2009
    Publication date: August 4, 2011
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Howard Hutchinson, Thomas Jon Seiders, Bowei Wang, Jeannie M. Arruda, Brian Andrew Stearns, Jeffrey Roger Roppe
  • 5-lipdxygenase-activating protein (FLAP) inhibitors
    Patent number: 7977359
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: July 12, 2011
    Assignee: Amira Pharmaceuticals, Inc.
    Inventors: John H. Hutchinson, Petpiboon Peppi Prasit, Mark Moran, Jillian F. Evans, Brian Andrew Stearns, Jeffrey Roger Roppe, Yiwei Li, Jasmine Eleanor Zunic, Jeannie M. Arruda, Nicholas Simon Stock, Mustapha Haddach
  • CYCLOALKANE[B]INDOLE ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110152338
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: June 23, 2009
    Publication date: June 23, 2011
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Yen Pham Truong
  • Antagonists of Prostaglandin D2 Receptors
    Publication number: 20110144160
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: July 2, 2009
    Publication date: June 16, 2011
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Howard Hutchinson, Thomas Jon Seiders, Bowei Wang, Jeannie M. Arruda, Brian Andrew Stearns
  • Methods and systems for dynamic scan compression
    Patent number: 7957598
    Abstract: A method for compressing data includes transmitting a requested compression factor such as a quality factor known in JPEG compression, to a scanner or like peripheral device. The type of communication link between the scanner or like device and a host computer is identified, and based on the communication link type, the requested compression factor is altered to generate a new compression factor subsequently used to compress the data. The amount of buffer, such as scan buffer, used by the scanner or peripheral device may also be used to alter the compression factor prior to compression.
    Type: Grant
    Filed: January 9, 2006
    Date of Patent: June 7, 2011
    Assignee: Lexmark International, Inc.
    Inventors: John Booth Bates, Brian Andrew Brown, Timothy John Rademacher
  • AMINOALKYLPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110130453
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: March 25, 2009
    Publication date: June 2, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Yen Pham Truong, Thomas Jon Seiders
  • METHOD AND SYSTEM FOR FACILITATING SHIPPING VIA A THIRD PARTY PAYMENT SERVICE
    Publication number: 20110119164
    Abstract: A system and method for a web server hosted by a third-party payment service is disclosed. Shipping information for a package is received from a client computer operated by a sender party. A shipping label associated with the package is generated in response to the receipt of the shipping information. The shipping label is sent to the client computer such that the shipping label can be printed out at the client computer.
    Type: Application
    Filed: November 11, 2010
    Publication date: May 19, 2011
    Inventors: Brian Andrew Phillips, Chad Meredith Hurley, Greg Cervelli, Ki Ching Wong, Paul Arthur Martin, Steve Chen, Yu Pan
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20110118315
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: January 24, 2011
    Publication date: May 19, 2011
    Inventors: John H. Hutchinson, Petpiboon Peppi Prasit, Mark Moran, Jillian F. Evans, Yiwei Li, Jasmine Eleanor Zunic, Jeannie M. Arruda, Nicholas Simon Stock, Brian Andrew Stearns, Mustapha Haddach, Jeffrey Roger Roppe
  • TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
    Publication number: 20110112106
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.
    Type: Application
    Filed: January 7, 2011
    Publication date: May 12, 2011
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Howard HUTCHINSON, Thomas Jonathan SEIDERS, Brian Andrew STEARNS, Bowei WANG, Jill Melissa SCOTT, Yen Pham TRUONG
  • Tricyclic Antagonists of Prostaglandin D2 Receptors
    Publication number: 20110112134
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: January 15, 2009
    Publication date: May 12, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Ryan Clark
  • N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110098352
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: January 29, 2009
    Publication date: April 28, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Jill Melissa Scott, Yen Pham Truong, Jeffrey Roger Roppe, Nicholas Simon Stock, Jeannie M. Arruda, Thomas Jon Seiders, Bowei Wang
  • CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110098302
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: February 12, 2009
    Publication date: April 28, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Thomas Jon Seiders, Brian Andrew Stearns, Bowei Wang, Yen Pham Truong, Jeannie M. Arruda
  • POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
    Publication number: 20110082164
    Abstract: Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
    Type: Application
    Filed: September 29, 2010
    Publication date: April 7, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: Ryan CLARK, Brian Andrew STEARNS, Lucy ZHAO, Thomas Jon SEIDERS, Deborah VOLKOTS, Jeannie M. ARRUDA
  • Compounds as Lysophosphatidic Acid Receptor Antagonists
    Publication number: 20110082181
    Abstract: Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
    Type: Application
    Filed: October 1, 2010
    Publication date: April 7, 2011
    Applicant: Amira Phamaceuticals, Inc.
    Inventors: Thomas Jon SEIDERS, Lucy Zhao, Jeannie M. Arruda, Brian Andrew Stearns, Yen Pham Truong, Jill Melissa Scott, John Howard Hutchinson, Nicholas Simon Stock, Deborah Volkots
  • Tricyclic inhibitors of 5-lipoxygenase
    Patent number: 7919621
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: April 5, 2011
    Assignee: Amira Pharmaceuticals, Inc.
    Inventors: John Howard Hutchinson, Thomas Jonathan Seiders, Brian Andrew Stearns, Bowei Wang
  • N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110039852
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein that are antagonists of PGD2 receptors. Also described herein are methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: January 29, 2009
    Publication date: February 17, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Jill Melissa Scott, Yen Pham Truong, Jeffrey Roger Roppe, Nicholas Simon Stock, Jeannie M. Arruda, Thomas Jon Seiders, Bowei Wang, Deborah Volkots
  • DP2 Antagonist and Uses Thereof
    Publication number: 20110034558
    Abstract: Described herein is the DP2 antagonist [2?-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4?-trifluoromethyl-biphenyl-3-yl]-acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the DP2 antagonist, or a pharmaceutically acceptable salt thereof. Also described herein are pharmaceutical compositions suitable for administration to a mammal that include the DP2 antagonist, or a pharmaceutically acceptable salt thereof, and methods of using such pharmaceutical compositions for treating respiratory diseases or conditions, allergic diseases or conditions, inflammatory diseases or conditions, as well as other prostaglandin D2-dependent or prostaglandin D2-mediated diseases or conditions.
    Type: Application
    Filed: July 29, 2010
    Publication date: February 10, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: Jason Edward BRITTAIN, Brian Andrew STEARNS, Christopher David KING, Kevin Ross HOLME
  • HEAVY-DUTY QUAD SEAL PLASTIC BAG WITH SIDE HANDLE HOLES
    Publication number: 20110019937
    Abstract: A heavy-duty plastic bag is comprised of a flat front panel, a back panel and gusseted longitudinal side panels. One of the gusseted longitudinal side panels has extended opposed gusseted side walls to form bag carrying end panels. The bag carrying end panels are sealed with one another and are each provided with three spaced-apart handle holes for ease of carrying the bag by one or both ends of a person with the bag disposed horizontally to facilitate manipulation in carrying of the bag. The bag carrying end panels provide for reinforced hand holes and comfort to the hands of a user person. The gusseted side panels and front and back panels provide a heavy-duty plastic bag with four display panels.
    Type: Application
    Filed: July 21, 2009
    Publication date: January 27, 2011
    Applicant: HOOD PACKAGING CORPORATION
    Inventors: Brian John STEINWAGNER, Kerry Lee RING, Brian Andrew MUNSTERMAN
  • ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
    Publication number: 20110021573
    Abstract: Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 27, 2011
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Howard Hutchinson, Brian Andrew Stearns, Thomas Jonathan Seiders, Jill Melissa Scott, Jeannie M. Arruda, Bowei Wang
  • Multiple camera imaging method and system for detecting concealed objects
    Patent number: 7873182
    Abstract: The present invention is an imaging system for detecting concealed objects on an individual. The imaging system includes an imaging zone that is illuminated with millimeter wave energy. A plurality of millimeter wave cameras are focused to fully surround the imaging zone and have the ability to detect millimeter wave frequencies reflected from the imaging zone. As an individual passes through the imaging zone the plurality of millimeter wave cameras detect concealed objects by identifying differences in the millimeter wave energy reflected by the individual's body and a concealed object. A composite image is generated by a central processing unit and displayed on a monitor showing the concealed object on the individual through optical contrast.
    Type: Grant
    Filed: August 8, 2007
    Date of Patent: January 18, 2011
    Assignee: Brijot Imaging Systems, Inc.
    Inventors: Brian Andrew, John Carter